Dr. Prasad Narayanan – Medical & Hemato-Oncologist in Bengaluru

Dr. Prasad Narayanan is a Lead Consultant in Medical Oncology, Hemato-Oncology and Bone Marrow Transplantation at Manipal Hospital, Yelahanka, Bengaluru. He has more than 28 years of overall experience and over 17 years of specialist experience in oncology.

Dr. Prasad completed his MBBS, followed by MD in General Medicine and DM in Oncology from Tata Memorial Hospital, Mumbai. He has developed extensive expertise in the management of solid tumours, blood cancers and complex oncological conditions.

His areas of clinical interest include medical oncology, hemato-oncology, bone marrow transplantation, cancer immunotherapy, cell therapy and precision cancer treatment. He has also been involved in clinical and translational research, teaching and academic activities.

Dr. Prasad has significant experience in stem cell transplantation and has conducted more than 200 stem cell transplants, including autologous, allogeneic, haploidentical and cord blood transplantation, during his professional career.

His clinical interests include the treatment of breast cancer, lung cancer, head and neck cancers, colorectal cancer, gastrointestinal cancers, gynecological malignancies and hematological cancers.

Dr. Prasad follows a personalised approach to cancer care, combining detailed evaluation with appropriate chemotherapy, immunotherapy, targeted treatment, cell therapy and transplantation when clinically indicated. His approach focuses on evidence-based treatment, multidisciplinary care and clear communication with patients and families.

Dr. Prasad Narayanan's Oncology Treatments

Medical Oncology

Comprehensive medical treatment and management of solid tumours and other cancers using appropriate systemic therapies.

Hemato-Oncology

Specialist management of blood cancers and other hematological malignancies.

Bone Marrow Transplantation

Stem cell and bone marrow transplantation for appropriately selected patients with blood cancers and other serious conditions.

Cancer Immunotherapy

Advanced cancer treatment that uses the patient's immune system to help recognise and fight cancer cells.

Cell Therapy

Advanced cellular treatment approaches for selected cancers and hematological conditions.

Precision Cancer Therapy

Individualised cancer treatment based on tumour characteristics, molecular findings and the patient's clinical condition.

Breast Cancer Treatment

Medical management of breast cancer using chemotherapy, targeted therapy, hormonal treatment, immunotherapy or other appropriate options.

Lung Cancer Treatment

Comprehensive medical oncology care for selected lung cancer conditions and stages.

Head and Neck Cancer Treatment

Systemic cancer treatment and multidisciplinary management for selected head and neck malignancies.

Colorectal Cancer Treatment

Medical oncology management of colon and rectal cancers using appropriate systemic treatment protocols.

Gastrointestinal Cancer Treatment

Specialist medical management of cancers affecting the digestive system.

Gynecologic Cancer Treatment

Medical oncology care for selected cancers affecting the female reproductive system.

Blood Cancer Treatment

Medical management of leukemia, lymphoma, myeloma and other hematological malignancies.

Leukemia Treatment

Specialist evaluation and systemic treatment for acute and chronic forms of leukemia.

Lymphoma Treatment

Medical management of Hodgkin and non-Hodgkin lymphoma using appropriate systemic treatment approaches.

Multiple Myeloma Treatment

Comprehensive medical management of multiple myeloma using appropriate systemic and supportive treatment.

Chemotherapy

Use of anti-cancer medicines to destroy or control cancer cells as part of an individualised treatment plan.

Targeted Therapy

Cancer treatment using medicines designed to act on specific molecular or biological features of cancer cells.

Hormone Therapy

Systemic treatment that blocks or modifies hormone activity in selected hormone-sensitive cancers.

Stem Cell Transplantation

Autologous and allogeneic stem cell transplantation for appropriately selected patients with hematological malignancies and other conditions.